Market Overview:
The global D-(+)-3-bromocamphor market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for D-(+)-3-bromocamphor in various applications such as organic synthesis intermediate, pharmaceutical intermediate, and others. Additionally, the growing demand for D-(+)-3-bromocamphor from emerging economies is also contributing to the growth of this market. However, volatility in prices of raw materials used in manufacturing D-(+)-3-bromocamphor may restrain the growth of this market during the forecast period.
-3-Bromocamphor(CAS 10293-06-8) Industry Outlook.svg)
Product Definition:
D-(+)-3-Bromocamphor is a chiral molecule that is used as a ligand in asymmetric catalysis.
purity Above98%:
Purity Above98% is a special grade of bromocamphors developed for the pharmaceutical industry. It has been used to formulate several medicines and drug products globally.
It means that all ingredients in the final product should contain a minimum quantity of 0 - 2%. In other words, it's more than 99.5%, but less than 100%.
purity=98%:
Purity 98% is a colorless liquid, which is used as an intermediate in the production of various chemicals. It can be also used as a solvent and in pharmaceuticals. Purity 98% has applications in industries such as pharmaceuticals, agrochemical, research laboratories and other industrial sectors.
It can be produced by chemical synthesis or hydrolysis ofcamphor (CAS 10293-06-8).
Application Insights:
Organic synthesis intermediate was the dominant application segment and accounted for over 50% of the global demand in 2016. The product is widely used in organic synthesis as a nucleophile towards deprotonation of alkyl halides, carbonate esters and enolates. D-Camphor has been an important intermediate in several industrial processes such as camphorsulfonic acid production, d-limonene sulfonation process, camphene oxidation to produce p-tertiary butylbenzene (TBB), etc.
Pharmaceutical intermediates are expected to be one of the fastest growing applications on account of its rising use as an active pharmaceutical ingredient (API) drug candidate for treatment purposes across various diseases such as Parkinson¢â‚¬â„¢s disease, epilepsy, anxiety disorders & depression among others. However, high cost associated with these drugs restrict their consumption within developed regions which may hinder growth during forecast years.
Regional Analysis:
Asia Pacific is expected to be the fastest-growing region with a CAGR of XX% from 2018 to 2030 owing to increasing product demand in pharmaceutical and organic synthesis industries. The presence of key manufacturers such as Shandong Tianzhan Pharmaceutical (Group) Co., Ltd., China; Nippon Chemical & Petrochemical Corp.; and Indian Rare Earths Limited, which are engaged in large scale production of dibromocamphor will drive the regional market growth over the forecast period.
The European market for 3-bromo camphor was valued at USD X million in 2017 and is anticipated to witness slow growth due its low consumption rate as compared to other regions globally.
Growth Factors:
- Increasing demand from end-use industries such as pharmaceuticals, agrochemicals, and flavors and fragrances is expected to drive the growth of the D-(+)-3-bromocamphor market during the forecast period.
- The increasing use of D-(+)-3-bromocamphor in various applications such as solvents, intermediates, and pesticides is also projected to fuel market growth over the next few years.
- Growing research and development activities for new applications of D-(+)-3-bromocamphor are anticipated to provide numerous opportunities for market expansion in the near future.
- The rising popularity of Bromocriptine mesylate (CAS 10293-06-8) as a therapeutic agent is expected to create potential demand for D-(+)-3 bromocamphor in this segment over the forecast period. 5
Scope Of The Report
Report Attributes
Report Details
Report Title
D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Research Report
By Type
purity Above98%, purity=98%
By Application
Organic Synthesis Intermediate, Pharmaceutical Intermediate, Others
By Companies
Hangzhoudauang Chem, Tokyo Chemical Industry Co., LTD, Hairui, Norna Group, Yonghe Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Report Segments:
The global D-(+)-3-Bromocamphor(CAS 10293-06-8) market is segmented on the basis of:
Types
purity Above98%, purity=98%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Organic Synthesis Intermediate, Pharmaceutical Intermediate, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hangzhoudauang Chem
- Tokyo Chemical Industry Co., LTD
- Hairui
- Norna Group
- Yonghe Chemical
-3-Bromocamphor(CAS 10293-06-8) Market Overview.svg)
Highlights of The D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- purity Above98%
- purity=98%
- By Application:
- Organic Synthesis Intermediate
- Pharmaceutical Intermediate
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the D-(+)-3-Bromocamphor(CAS 10293-06-8) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
-3-Bromocamphor(CAS 10293-06-8) Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
D-(+)-3-Bromocamphor is a chemical compound with the molecular formula C10293-06-8. It is a colorless liquid with a sweet odor. D-(+)-3-Bromocamphor is used in research as an insecticide and fungicide.
Some of the major players in the d-(+)-3-bromocamphor(cas 10293-06-8) market are Hangzhoudauang Chem, Tokyo Chemical Industry Co., LTD, Hairui, Norna Group, Yonghe Chemical.
The d-(+)-3-bromocamphor(cas 10293-06-8) market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. D-(+)-3-Bromocamphor(CAS 10293-06-8) Market - Supply Chain
4.5. Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Forecast
4.5.1. D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size (000 Units) and Y-o-Y Growth
4.5.3. D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Absolute $ Opportunity
5. Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size and Volume Forecast by Type
5.3.1. purity Above98%
5.3.2. purity=98%
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size and Volume Forecast by Application
6.3.1. Organic Synthesis Intermediate
6.3.2. Pharmaceutical Intermediate
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Demand Share Forecast, 2019-2026
9. North America D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size and Volume Forecast by Application
9.4.1. Organic Synthesis Intermediate
9.4.2. Pharmaceutical Intermediate
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size and Volume Forecast by Type
9.7.1. purity Above98%
9.7.2. purity=98%
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America D-(+)-3-Bromocamphor(CAS 10293-06-8) Demand Share Forecast, 2019-2026
10. Latin America D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size and Volume Forecast by Application
10.4.1. Organic Synthesis Intermediate
10.4.2. Pharmaceutical Intermediate
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size and Volume Forecast by Type
10.7.1. purity Above98%
10.7.2. purity=98%
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America D-(+)-3-Bromocamphor(CAS 10293-06-8) Demand Share Forecast, 2019-2026
11. Europe D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size and Volume Forecast by Application
11.4.1. Organic Synthesis Intermediate
11.4.2. Pharmaceutical Intermediate
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size and Volume Forecast by Type
1.7.1. purity Above98%
11.7.2. purity=98%
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe D-(+)-3-Bromocamphor(CAS 10293-06-8) Demand Share, 2019-2026
12. Asia Pacific D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size and Volume Forecast by Application
12.4.1. Organic Synthesis Intermediate
12.4.2. Pharmaceutical Intermediate
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size and Volume Forecast by Type
12.7.1. purity Above98%
12.7.2. purity=98%
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific D-(+)-3-Bromocamphor(CAS 10293-06-8) Demand Share, 2019-2026
13. Middle East & Africa D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size and Volume Forecast by Application
13.4.1. Organic Synthesis Intermediate
13.4.2. Pharmaceutical Intermediate
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa D-(+)-3-Bromocamphor(CAS 10293-06-8) Market Size and Volume Forecast by Type
13.7.1. purity Above98%
13.7.2. purity=98%
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa D-(+)-3-Bromocamphor(CAS 10293-06-8) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global D-(+)-3-Bromocamphor(CAS 10293-06-8) Market: Market Share Analysis
14.2. D-(+)-3-Bromocamphor(CAS 10293-06-8) Distributors and Customers
14.3. D-(+)-3-Bromocamphor(CAS 10293-06-8) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Hangzhoudauang Chem
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Tokyo Chemical Industry Co., LTD
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Hairui
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Norna Group
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Yonghe Chemical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
